We serve Chemical Name:4-(trifluoromethyl)pyridine-3-carbothioamide CAS:158063-54-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(trifluoromethyl)pyridine-3-carbothioamide
CAS.NO:158063-54-8
Synonyms:4-(trifluoromethyl)-3-Pyridinecarbothioamide;4-(TRIFLUOROMETHYL)PYRIDINE-3-THIOCARBOXAMIDE;4-Trifluoromethyl-thionicotinamide
Molecular Formula:C7H5F3N2S
Molecular Weight:206.18800
HS Code:
Physical and Chemical Properties:
Melting point:153ºC
Boiling point:290.4ºC at 760mmHg
Density:1.484g/cm3
Index of Refraction:1.55
PSA:71.00000
Exact Mass:206.01300
LogP:2.43490
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(trifluoromethyl)-3-Pyridinecarbothioamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Trifluoromethyl-thionicotinamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(trifluoromethyl)-3-Pyridinecarbothioamide Use and application,4-Trifluoromethyl-thionicotinamide technical grade,usp/ep/jp grade.
Related News: Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. 4-fluoro-6-phenoxypyrimidin-2-amine manufacturers The relationship between a CDMO and the company also depends on influencing aspects such as transparent communication, involvement at every step, and support while dealing with challenges. 2-(2-Bromoethoxy)tetrahydro-2H-pyran suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. 2-bromo-N-(3-methoxypropyl)benzenesulfonamide vendor & factory “We’re going to further invest in research and development to continue to build our pipeline of products, in a more sophisticated way,” he says, holding up a pocket-sized wearable device and a tiny insulin pen to his screen’s camera. “We really believe in this business for the next—we hope—70 years.”,“We’re going to further invest in research and development to continue to build our pipeline of products, in a more sophisticated way,” he says, holding up a pocket-sized wearable device and a tiny insulin pen to his screen’s camera. “We really believe in this business for the next—we hope—70 years.”
